insights_auto
Pse është ulur LLY 3,78%?
Zhytu më thellëchevron_right
LLY:NYSE
Eli Lilly And Co
1Â 364,73Â US$
arrow_downward
-3,78%(-53,58) 1D
1Â 359,74Â US$
arrow_downward
-0,37% (-4,99)bedtimeJashtë orarit
Mbyllur: 5 nĂ«n, 4:04:36 m.d., GMT-5 · USD
search
TĂ« gjitha simbolet
| Me simbole | Çmimi | Ndrysho | % ndryshim |
|---|
insights_autoPo gjenerohen statistikat kryesore për LLY...
Hap
1Â 434,00Â US$
I lartë
1Â 453,00Â US$
I ulët
1Â 364,73Â US$
Kapitalizimi i tregut
1,28Â bln
VĂ«llimi mesatar
2,55Â mln
VĂ«llimi
4,88Â mln
Dividendi
0,51%
Dividendi tremujor
1,73Â US$
Data e ndërprerjes së dividendit
14 gush 2026
Raporti çmim/fitim
44,30
Maksimumi 52-javor
1Â 453,00Â US$
Minimumi 52-javor
850,51Â US$
Fitimet për aksion
30,81Â US$
Beta
0,40
Aksionet në qarkullim
940,74Â mln
Numri i punonjësve
50 mijë
Hap
1Â 434,00Â US$
I lartë
1Â 453,00Â US$
I ulët
1Â 364,73Â US$
Kapitalizimi i tregut
1,28Â bln
VĂ«llimi mesatar
2,55Â mln
VĂ«llimi
4,88Â mln
Dividendi
0,51%
Dividendi tremujor
1,73Â US$
Data e ndërprerjes së dividendit
14 gush 2026
Raporti çmim/fitim
44,30
Maksimumi 52-javor
1Â 453,00Â US$
Minimumi 52-javor
850,51Â US$
Fitimet për aksion
30,81Â US$
Beta
0,40
Aksionet në qarkullim
940,74Â mln
Numri i punonjësve
50 mijë
Lajmet
Nga burimet në ueb dhe partnerët e lajmeve
GuruFocus
·
11 minuta më parë
US Preventive Services Task Force Stock Waivers Spotlight Eli Li
Zacks Investment Research
·
1 orë më parë
2 Defensive Healthcare Stocks Hitting New 52-Week Highs: ABBV & LLY
Zacks
·
1 orë më parë
AI and Tech Selloff Heats Up: Buy Big Pharma Stock LLY as a Safe Haven?
Yahoo Finance
·
2 orë më parë
AI and Tech Selloff Heats Up: Buy Big Pharma Stock LLY as a Safe Haven?
Profili
Eli Lilly and Company, doing business as Lilly, is an American multinational pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 36 countries. Its products are marketed in approximately 90 countries. The company was founded in 1876 by Eli Lilly, a pharmaceutical chemist and Union army veteran during the American Civil War for whom the company was later named.
The company is ranked 4th on the list of largest biomedical companies by revenue and is the most valuable pharmaceutical company worldwide. It is ranked 100th on the Fortune 500 and 138th on the Forbes Global 2000. In November 2025, the company reached a $1 trillion market capitalization, the first health-care company in the world to do so.
The company's primary products are tirzepatide for the treatment of type 2 diabetes, weight loss, and obstructive sleep apnea; abemaciclib for the treatment of advanced or metastatic breast cancers; dulaglutide for the treatment of type 2 diabetes; ixekizumab for the treatment of autoimmune diseases; and empagliflozin for the treatment of type 2 diabetes. Wikipedia
Rreth Eli Lilly And Co
Drejtori ekzekutivDavid A. Ricks
Punonjësit50 mijë
Themeluar më1876
SeliaIndianapolis, Indiana, Shtetet e Bashkuara të Amerikës
SektoriHealth Care
Industry-
Uebsajtililly.com